Biogeography of the ecosystems of the healthy human body

Background

Characterizing the biogeography of the microbiome of healthy humans is essential for understanding microbial associated diseases. Previous studies mainly focused on a single body habitat from a limited set of subjects. Here, we analyzed one of the largest microbiome datasets to date and generated a biogeographical map that annotates the biodiversity, spatial relationships, and temporal stability of 22 habitats from 279 healthy humans.

Results

We identified 929 genera from more than 24 million 16S rRNA gene sequences of 22 habitats, and we provide a baseline of inter-subject variation for healthy adults. The oral habitat has the most stable microbiota with the highest alpha diversity, while the skin and vaginal microbiota are less stable and show lower alpha diversity. The level of biodiversity in one habitat is independent of the biodiversity of other habitats in the same individual. The abundances of a given genus at a body site in which it dominates do not correlate with the abundances at body sites where it is not dominant. Additionally, we observed the human microbiota exhibit both cosmopolitan and endemic features. Finally, comparing datasets of different projects revealed a project-based clustering pattern, emphasizing the significance of standardization of metagenomic studies.

Conclusions

The data presented here extend the definition of the human microbiome by providing a more complete and accurate picture of human microbiome biogeography, addressing questions best answered by a large dataset of subjects and body sites that are deeply sampled by sequencing.     

Drosophila Growth Cones Advance by Forward Translocation of the Neuronal Cytoskeletal Meshwork In Vivo

In vitro studies conducted in Aplysia and chick sensory neurons indicate that in addition to microtubule assembly, long microtubules in the C-domain of the growth cone move forward as a coherent bundle during axonal elongation. Nonetheless, whether this mode of microtubule translocation contributes to growth cone motility in vivo is unknown. To address this question, we turned to the model system Drosophila. Using docked mitochondria as fiduciary markers for the translocation of long microtubules, we first examined motion along the axon to test if the pattern of axonal elongation is conserved between Drosophila and other species in vitro. When Drosophila neurons were cultured on Drosophila extracellular matrix proteins collected from the Drosophila Kc167 cell line, docked mitochondria moved in a pattern indicative of bulk microtubule translocation, similar to that observed in chick sensory neurons grown on laminin. To investigate whether the C-domain is stationary or advances in vivo, we tracked the movement of mitochondria during elongation of the aCC motor neuron in stage 16 Drosophila embryos. We found docked mitochondria moved forward along the axon shaft and in the growth cone C-domain. This work confirms that the physical mechanism of growth cone advance is similar between Drosophila and vertebrate neurons and suggests forward translocation of the microtubule meshwork in the axon underlies the advance of the growth cone C-domain in vivo. These results highlight the need for incorporating en masse microtubule translocation, in addition to assembly, into models of axonal elongation.     

β-Globin Sleeping Beauty Transposon Reduces Red Blood Cell Sickling in a Patient-Derived CD34+-Based In Vitro Model

The ultimate goal of gene therapy for sickle cell anemia (SCA) is an improved phenotype for the patient. In this study, we utilized bone marrow from a sickle cell patient as a model of disease in an in vitro setting for the hyperactive Sleeping Beauty transposon gene therapy system. We demonstrated that mature sickle red blood cells containing hemoglobin-S and sickling in response to metabisulfite can be generated in vitro from SCA bone marrow. These cells showed the characteristic morphology and kinetics of hemoglobin-S polymerization, which we quantified using video microscopy and imaging cytometry. Using video assessment, we showed that delivery of an IHK-β^T87Q antisickling globin gene by Sleeping Beauty via nucleofection improves metrics of sickling, decreasing percent sickled from 53.2 ± 2.2% to 43.9 ± 2.0%, increasing the median time to sickling from 8.5 to 9.6 min and decreasing the maximum rate of sickling from 2.3 x 10^-3 sickling cells/total cells/sec in controls to 1.26 x 10^-3 sickling cells/total cells/sec in the IHK-β^T87Q-globin group (p < 0.001). Using imaging cytometry, the percentage of elongated sickled cells decreased from 34.8 ± 4.5% to 29.5 ± 3.0% in control versus treated (p < 0.05). These results support the potential use of Sleeping Beauty as a clinical gene therapy vector and provide a useful tool for studying sickle red blood cells in vitro.     

Within-laboratory and between-laboratory variability in the measurement of anti-müllerian hormone determined within an external quality assurance scheme

Ten laboratories in an external quality assurance scheme used the same assay to measure anti-müllerian hormone concentration (Beckman Coulter Gen II) and received twenty serum samples distributed over a 15 month period. The mean bias for all results was only ?0.089%, but there was large coefficient of repeatability of 38.8% (sample bias ranged from ?37.9% to +54.7%). While each laboratory showed good reproducibility, there was a wide range of average values relative to the consensus value from ?24.0% to +22.7%. This between-laboratory variability suggests clinicians should use the same laboratory to avoid problems with result interpretation.     

Metabolic profiling of human saliva before and after induced physiological stress by ultra-high performance liquid chromatography–ion mobility–mass spectrometry

A method has been developed for metabolite profiling of the salivary metabolome based on protein precipitation and ultra-high performance liquid chromatography coupled with ion mobility-mass spectrometry (UHPLC–IM–MS). The developed method requires 0.5 mL of human saliva, which is easily obtainable by passive drool. Standard protocols have been established for the collection, storage and pre-treatment of saliva. The use of UHPLC allows rapid global metabolic profiling for biomarker discovery with a cycle time of 15 min. Mass spectrometry imparts the ability to analyse a diverse number of species reproducibly over a wide dynamic range, which is essential for profiling of biofluids. The combination of UHPLC with IM–MS provides an added dimension enabling complex metabolic samples to be separated on the basis of retention time, ion mobility and mass-to-charge ratio in a single chromatographic run. The developed method has been applied to targeted metabolite identification and untargeted metabolite profiling of saliva samples collected before and after exercise-induced physiological stress. δ-Valerolactam has been identified as a potential biomarker on the basis of retention time, MS/MS spectrum and ion mobility drift time.     

Molecular characterisation of acanthocephalans from Australian marine teleosts: proposal of a new family,synonymy of another and transfer of taxa between orders

We provide molecular data (cox1, 18S rDNA and 28S rDNA) for 17 acanthocephalan species and 20 host-parasite combinations from Australian marine teleosts collected from off Queensland, Australia. Fourteen of these acanthocephalans are characterised with molecular data for the first time and we provide the first molecular data for a species of each of the genera Heterosentis Van Cleave, 1931, Pyriproboscis Amin, Abdullah & Mhaisen, 2003 and Sclerocollum Schmidt & Paperna, 1978. Using 18S and 28S rDNA sequences, the phylogenetic position of each newly sequenced species is assessed with both single-gene and concatenated 18S+28S maximum likelihood and Bayesian inference analyses. Additional phylogenetic analyses focusing on the genus Rhadinorhynchus Lühe, 1912 and related lineages are included. Our phylogenetic results are broadly consistent with previous analyses, recovering previously identified inconsistencies but also providing new insights and necessitating taxonomic action. We do not find sufficient evidence to recognise the Gymnorhadinorhynchidae Braicovich, Lanfranchi, Farber, Marvaldi, Luque & Timi, 2014 as distinct from the Rhadinorhynchidae Lühe, 1912. The family Gymnorhadinorhynchidae and its sole genus, Gymnorhadinorhynchus Braicovich, Lanfranchi, Farber, Marvaldi, Luque & Timi, 2014, are here recognised as junior synonyms of Rhadinorhynchidae and Rhadinorhynchus, respectively. The two species currently assigned to Gymnorhadinorhynchus are recombined as Rhadinorhynchus decapteri (Braicovich, Lanfranchi, Farber, Marvaldi, Luque & Timi, 2014) n. comb. and Rhadinorhynchus mariserpentis (Steinauer, Garcia-Vedrenne, Weinstein & Kuris, 2019) n. comb. In all of our analyses, Rhadinorhynchus biformis Smales, 2014 is found basal to the Rhadinorhynchidae + Transvenidae Pichelin & Cribb, 2001, thus resulting in a paraphyletic Rhadinorhynchidae. It appears that R. biformis may require a new genus and family; however, morphological data for this species are currently insufficient to adequately distinguish it from related lineages, thus we defer the proposal of any new higher-rank names for this species. Species of the genus Sclerocollum, currently assigned to the Cavisomidae Meyer, 1932, are found nested within the family Transvenidae. We transfer the genus Sclerocollum to the Transvenidae and amend the diagnosis of the family accordingly. The genera Gorgorhynchoides Cable & Linderoth, 1963 and Serrasentis Van Cleave, 1923, currently assigned to the Rhadinorhynchidae, are supported as sister taxa and form a clade in the Polymorphida. We transfer these genera and Golvanorhynchus Noronha, Fabio & Pinto, 1978 to an emended concept of the Isthomosacanthidae Smales, 2012 and transfer this family to the Polymorphida. Lastly, Pyriproboscis heronensis (Pichelin, 1997) Amin, Abdullah & Mhaisen, 2003, currently assigned to the Pomphorhynchidae Yamaguti, 1939, falls under the Polymorphida in our analyses with some support for a sister relationship with the Centrorhynchidae Van Cleave, 1916. As this species clearly does not belong in the Pomphorhynchidae and is morphologically and molecularly distinct from the lineages of the Polymorphida, we propose the Pyriprobosicidae n. fam. to accommodate it.

     

Insulin resistance dysregulates CYP7B1 leading to oxysterol accumulation: a pathway for NAFL to NASH transition

NAFLD is an important public health issue closely associated with the pervasive epidemics of diabetes and obesity. Yet, despite NAFLD being among the most common of chronic liver diseases, the biological factors responsible for its transition from benign nonalcoholic fatty liver (NAFL) to NASH remain unclear. This lack of knowledge leads to a decreased ability to find relevant animal models, predict disease progression, or develop clinical treatments. In the current study, we used multiple mouse models of NAFLD, human correlation data, and selective gene overexpression of steroidogenic acute regulatory protein (StarD1) in mice to elucidate a plausible mechanistic pathway for promoting the transition from NAFL to NASH. We show that oxysterol 7α-hydroxylase (CYP7B1) controls the levels of intracellular regulatory oxysterols generated by the “acidic/alternative” pathway of cholesterol metabolism. Specifically, we report data showing that an inability to upregulate CYP7B1, in the setting of insulin resistance, results in the accumulation of toxic intracellular cholesterol metabolites that promote inflammation and hepatocyte injury. This metabolic pathway, initiated and exacerbated by insulin resistance, offers insight into approaches for the treatment of NAFLD.